Further, S100A16 was found to suppress the expression of ZO-2 through ubiquitylation and degradation, thereby contributing to epithelial-mesenchymal transition (EMT) and the invasion of GC cells [18]. This evidence concerns the gene S100A16 and gastric cancer.